Buck K - Search Results

1

The alpha(2) adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.

Buck K, Voehringer P, Ferger B. Buck K, et al. J Neurochem. 2010 Jan;112(2):444-52. doi: 10.1111/j.1471-4159.2009.06482.x. Epub 2009 Nov 6. J Neurochem. 2010. PMID: 19895663 Free article.

2

Comparison of intrastriatal administration of noradrenaline and l-DOPA on dyskinetic movements: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.

Buck K, Ferger B. Buck K, et al. Neuroscience. 2009 Mar 3;159(1):16-20. doi: 10.1016/j.neuroscience.2008.12.026. Epub 2008 Dec 24. Neuroscience. 2009. PMID: 19146929

3

Site-specific action of L-3,4-dihydroxyphenylalanine in the striatum but not globus pallidus and substantia nigra pars reticulata evokes dyskinetic movements in chronic L-3,4-dihydroxyphenylalanine-treated 6-hydroxydopamine-lesioned rats.

Buck K, Voehringer P, Ferger B. Buck K, et al. Neuroscience. 2010 Mar 17;166(2):355-8. doi: 10.1016/j.neuroscience.2009.12.032. Epub 2009 Dec 22. Neuroscience. 2010. PMID: 20026252

4

Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.

Buck K, Ferger B. Buck K, et al. Neurobiol Dis. 2008 Feb;29(2):210-20. doi: 10.1016/j.nbd.2007.08.010. Epub 2007 Aug 29. Neurobiol Dis. 2008. PMID: 17920284

5

Rapid analysis of GABA and glutamate in microdialysis samples using high performance liquid chromatography and tandem mass spectrometry.

Buck K, Voehringer P, Ferger B. Buck K, et al. J Neurosci Methods. 2009 Aug 30;182(1):78-84. doi: 10.1016/j.jneumeth.2009.05.018. Epub 2009 Jun 6. J Neurosci Methods. 2009. PMID: 19505500

6

The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

Buck K, Ferger B. Buck K, et al. Synapse. 2010 Feb;64(2):117-26. doi: 10.1002/syn.20709. Synapse. 2010. PMID: 19771592

7

Continuous dopaminergic stimulation by pramipexole is effective to treat early morning akinesia in animal models of Parkinson's disease: A pharmacokinetic-pharmacodynamic study using in vivo microdialysis in rats.

Ferger B, Buck K, Shimasaki M, Koros E, Voehringer P, Buerger E. Ferger B, et al. Among authors: buck k. Synapse. 2010 Jul;64(7):533-41. doi: 10.1002/syn.20759. Synapse. 2010. PMID: 20196139

8

L-DOPA-induced dyskinesia in Parkinson's disease: a drug discovery perspective.

Buck K, Ferger B. Buck K, et al. Drug Discov Today. 2010 Oct;15(19-20):867-75. doi: 10.1016/j.drudis.2010.08.014. Epub 2010 Aug 27. Drug Discov Today. 2010. PMID: 20801228 Review.

9

Effects of levodopa on striatal monoamines in mice with levodopa-induced hyperactivity.

Nicholas AP, Buck K, Ferger B. Nicholas AP, et al. Among authors: buck k. Neurosci Lett. 2008 Oct 10;443(3):204-8. doi: 10.1016/j.neulet.2008.07.039. Epub 2008 Jul 19. Neurosci Lett. 2008. PMID: 18657593

10

Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neurons.

Ulusoy A, Björklund T, Buck K, Kirik D. Ulusoy A, et al. Among authors: buck k. Neurobiol Dis. 2012 Sep;47(3):367-77. doi: 10.1016/j.nbd.2012.05.012. Epub 2012 May 31. Neurobiol Dis. 2012. PMID: 22659302

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters